Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Treatment of aggressive ADHD in children and adolescents: conceptualization and treatment of comorbid behavior disorders.

McBurnett K, Pfiffner LJ.

Postgrad Med. 2009 Nov;121(6):158-65. doi: 10.3810/pgm.2009.11.2084. Review.

PMID:
19940426
[PubMed - indexed for MEDLINE]
2.

[Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].

Wiesegger G, Kienbacher C, Pellegrini E, Scheidinger H, Vesely C, Bangerl W, Friedrich M.

Neuropsychiatr. 2007;21(3):187-206. Review. German.

PMID:
17915180
[PubMed - indexed for MEDLINE]
3.

Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness.

Waxmonsky J.

Curr Opin Pediatr. 2003 Oct;15(5):476-82. Review.

PMID:
14508296
[PubMed - indexed for MEDLINE]
4.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
[PubMed - indexed for MEDLINE]
5.

Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.

Pliszka SR.

J Clin Psychiatry. 1998;59 Suppl 7:50-8. Review.

PMID:
9680053
[PubMed - indexed for MEDLINE]
6.

International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions.

Kutcher S, Aman M, Brooks SJ, Buitelaar J, van Daalen E, Fegert J, Findling RL, Fisman S, Greenhill LL, Huss M, Kusumakar V, Pine D, Taylor E, Tyano S.

Eur Neuropsychopharmacol. 2004 Jan;14(1):11-28. Review.

PMID:
14659983
[PubMed - indexed for MEDLINE]
7.

Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management.

Pliszka SR.

Paediatr Drugs. 2003;5(11):741-50. Review.

PMID:
14580223
[PubMed - indexed for MEDLINE]
8.

Psychopharmacological treatment of oppositional defiant disorder.

Turgay A.

CNS Drugs. 2009;23(1):1-17. doi: 10.2165/0023210-200923010-00001. Review.

PMID:
19062772
[PubMed - indexed for MEDLINE]
9.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
[PubMed - indexed for MEDLINE]
10.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
[PubMed - indexed for MEDLINE]
11.

Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder.

Pliszka SR.

Child Adolesc Psychiatr Clin N Am. 2000 Jul;9(3):525-40, vii. Review.

PMID:
10944655
[PubMed - indexed for MEDLINE]
12.

Aggression and disruptive behavior disorders in children and adolescents.

Turgay A.

Expert Rev Neurother. 2004 Jul;4(4):623-32. Review.

PMID:
15853581
[PubMed - indexed for MEDLINE]
14.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
[PubMed - indexed for MEDLINE]
15.

Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).

[No authors listed]

NIH Consens Statement. 1998 Nov 16-18;16(2):1-37. Review.

PMID:
10868163
[PubMed - indexed for MEDLINE]
16.

Special considerations in diagnosing and treating attention-deficit/hyperactivity disorder.

Wigal SB, Wigal TL.

CNS Spectr. 2007 Jun;12(6 Suppl 9):1-14; quiz 15-6. Review.

PMID:
17545959
[PubMed - indexed for MEDLINE]
17.

Review of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.

Hazell P.

Australas Psychiatry. 2010 Dec;18(6):556-9. doi: 10.3109/10398562.2010.498049. Review.

PMID:
21117844
[PubMed - indexed for MEDLINE]
18.

Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting.

Jensen PS.

Am J Manag Care. 2009 May;15(5 Suppl):S129-40. Review.

PMID:
19601688
[PubMed - indexed for MEDLINE]
Free Article
19.

[Attention deficit hyperactivity disorders in children and adolescents: diagnostic and therapeutic guidelines].

Lehmkuhl G.

MMW Fortschr Med. 2007 May 21;149 Suppl 2:10-3; quiz 14. Review. German.

PMID:
17724960
[PubMed - indexed for MEDLINE]
20.

Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.

Harpin VA.

Arch Dis Child Educ Pract Ed. 2008 Apr;93(2):58-65. doi: 10.1136/adc.2006.106864. Review.

PMID:
18356307
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk